Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06748976 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Modulation of Cortical Brain Activity During Attentional Control

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 25, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 1, 2025 to Jul 1, 2025
    • Primary and study completion dates: Jun 2025 to Nov 2025
    • Site details revised
    v3
  2. Notable Start date: Feb 10, 2025 to Apr 1, 2025
    • Primary and study completion dates: Apr 2025 to Jun 2025
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description expanded, about 2 words
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to determine whether an open-loop sham neurofeedback system can effectively modulate EEG alpha rhythms, which are associated with attentional control. The main questions it aims to answer are: Does positive sham neurofeedback lead to a decrease in relative EEG alpha power compared to a control condition without feedback? Researchers will compare the effects of positive and negative sham-neurofeedback conditions to a control condition without feedback to assess the system's impact on alpha rhythm modulation. Participants will: Experience three conditions (positive sham-neurofeedback, negative sham-neurofeedback, and no feedback) within a virtual reality environment. Undergo EEG recordings to measure changes in alpha power as a marker of attentional resource allocation. Provide written informed consent and complete the study following ethical guidelines. This study seeks to explore the potential of open-loop feedback systems to enhance attentional control by modulating alpha rhythm.
Trial Details
NCT Number NCT06748976
Lead Sponsor National Council of Scientific and Technical Research, Argentina
Conditions
(from sponsor)
Rumination, Chronic Pain, Fibromyalgia
Related terms Chronic Pain, Fibromyalgia, Rumination Syndrome
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov